Product Information
XATMEP 2.5 MG/ML ORAL SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $21.7635 per ML under NDC 52652200106. Its NADAC has been published 47 times since Sep 18, 2024.
FDA first approved this application on Apr 25, 2017.
The High Outlier badge above means this manufacturer's average price in the Methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652200106
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHOTREXATEApproval Type
New Drug (NDA)
FDA Application
NDA208400FDA Approved
4/25/2017
On Market Since
5/1/2017
Pharmacological Classes
Price Statistics
The NADAC for XATMEP 2.5 MG/ML ORAL SOLUTION has been published 47 times since Sep 18, 2024, and over the history we have for it it has risen 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.7635 per ML |
|---|---|
| All-time high | $21.7635 (Aug 19, 2026) |
| All-time low | $19.3298 (Oct 23, 2024) |
| 52-week high | $21.7635 |
| 52-week low | $21.7635 |
| Median price | $21.0695 |
| Average price | $20.4602 |
| Largest weekly change | +9.0% (Jan 15, 2025) |
| Weeks tracked | 47 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XATMEP 2.5 MG/ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for XATMEP 2.5 MG/ML ORAL SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $21.7635 per ML (NDC 52652200106), effective Aug 19, 2026.
How has the price of XATMEP 2.5 MG/ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for XATMEP 2.5 MG/ML ORAL SOLUTION has risen 12.3%. It has been tracked across 47 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for XATMEP 2.5 MG/ML ORAL SOLUTION?
Since Sep 18, 2024, the NADAC for XATMEP 2.5 MG/ML ORAL SOLUTION has ranged from a low of $19.3298 (Oct 23, 2024) to a high of $21.7635 (Aug 19, 2026), with a median of $21.0695 per ML.
Are there cheaper alternatives to XATMEP 2.5 MG/ML ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of XATMEP 2.5 MG/ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XATMEP 2.5 MG/ML ORAL SOLUTION?
XATMEP 2.5 MG/ML ORAL SOLUTION (NDC 52652200106) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.